Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
perindopril arginine, Quantity: 5 mg
Medis Pharma Pty Ltd
perindopril arginine
Tablet, film coated
Excipient Ingredients: sodium starch glycollate type A; maltodextrin; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; glycerol dibehenate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350
Oral
30, 10
(S4) Prescription Only Medicine
The treatment of hypertension; The treatment of heart failure. In such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and Patients with established coronary artery disease (see Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
Visual Identification: White, oval, biconvex, film-coated tablets engraved with two dots on one side and scored on both sides; Container Type: Bottle; Container Material: HDPE; Container Life Time: 6 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2015-08-07